To unlock this feature and to subscribe to our weekly evidence emails, please create a FREE orthoEvidence account.

SIGNUP

Already Have an Account?

Loading...
Visit our Evidence-Based Covid-19 Website and Stay Up to Date with the latest Research.
Ace Report Cover

Diacutaneous Fibrolysis in Patients with Mild-Moderate Carpal Tunnel Syndrome

Download
Share
Reprints
Cite This
About
+ Favorites
Download
Share
Reprints
Cite This
About
+ Favorites
Ace Report Cover
October 2022

Diacutaneous Fibrolysis in Patients with Mild-Moderate Carpal Tunnel Syndrome

Vol: 298| Issue: 1| Number:3| ISSN#: 2564-2537
Study Type:Therapy
OE Level Evidence:1
Journal Level of Evidence:1

Diacutaneous Fibrolysis Intervention in Patients with Mild to Moderate Carpal Tunnel Syndrome May Avoid Severe Cases in Elderly: A Randomized Controlled Trial

Int J Environ Res Public Health. 2022 Sep 2;19(17):10983.

Contributing Authors:
S Jiménez-Del-Barrio L Ceballos-Laita E Bueno-Gracia S Rodríguez-Marco S Caudevilla-Polo E Estébanez-de-Miguel

Did you know you're eligible to earn 0.5 CME credits for reading this report? Click Here

Synopsis

Forty-four patients (60 wrists) with mild-moderate carpal tunnel syndrome were randomized to receive 5 sessions of diacutaneous fibrolysis treatment (n=20, 30 wrists) or a sham treatment (n=24, 30 wrists). The primary outcome of interest was the cross-sectional area of the median nerve. Secondary outcomes of interest included numbness on a Visual Analog Scale (VAS), the thickness of the transversa...

Join the Conversation

Please Login or Join to leave comments.